Clinical Trials Sponsored by K-PAX Pharmaceuticals, Inc.
Total 59 results
-
K-PAX Pharmaceuticals, Inc.UnknownChronic Fatigue Syndrome (CFS) | Myalgic Encephalomyelitis (ME)United States
-
K-PAX Pharmaceuticals, Inc.VA Palo Alto Health Care SystemUnknownGulf War IllnessUnited States
-
Par Pharmaceutical, Inc.Completed
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fed ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fasting Conditions
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fed ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fed ConditionsCanada
-
Par Pharmaceutical, Inc.AnapharmCompleted
-
Par Pharmaceutical, Inc.AnapharmCompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
Nobel PharmaceuticalsAinos, Inc. (f/k/a Amarillo Biosciences Inc.CompletedBehcet Syndrome | Behcet Disease | Mucocutaneous UlcerationTurkey
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompletedTo Determine the Bioequivalence Study Under FastingCanada
-
Par Pharmaceutical, Inc.PharmaKinetics Laboratories Inc.Completed
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompleted
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompleted
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompleted
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompleted
-
Par Pharmaceutical, Inc.PharmaKinetics Laboratories Inc.CompletedTo Determine Bioequivalence Under Fed ConditionsUnited States
-
Par Pharmaceutical, Inc.Algorithme Pharma IncCompletedTo Determine the Bioequivalence Study Under FedCanada
-
Par Pharmaceutical, Inc.AAI ClinicCompletedTo Determine Bioequivalence Under Fed Conditions
-
Par Pharmaceutical, Inc.AAI ClinicCompletedTo Determine Bioequivalence Under Fasting Conditions
-
Par Pharmaceutical, Inc.SFBC AnapharmCompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
Par Pharmaceutical, Inc.SFBC AnapharmCompletedTo Determine Bioequivalence Under Fed Conditions
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesTerminatedOtitis ExternaUnited States, Puerto Rico
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesCompletedTo Determine Bioequivalence Under Fed Conditions
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesTerminatedOtitis Media in Patients With Tympanostomy TubesUnited States
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesCompletedTo Determine the Bioequivalence Study Under Fasting
-
K-Group Alpha, Inc., a wholly owned subsidiary...RecruitingAcute Myeloid Leukemia (AML)United States
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingHigh-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerUnited States, Australia, France
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingUterine Serous CarcinomaUnited States, Australia, Canada, Georgia
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingFallopian Tube Cancer | Solid Tumor | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Australia, Bosnia and Herzegovina, Bulgaria, Georgia, Korea, Republic of, Serbia
-
K-Group Alpha, Inc., a wholly owned subsidiary...RecruitingAcute Myeloid Leukemia | Non Hodgkin LymphomaCroatia, Australia, Bulgaria, Korea, Republic of, Ukraine, Poland, Spain
-
K-Group Alpha, Inc., a wholly owned subsidiary...Active, not recruitingAL Amyloidosis | AmyloidosisSpain, Australia, Israel, United States, Greece, Italy, Cyprus
-
Par Pharmaceutical, Inc.SFBC Ft. Myers, IncCompletedTo Determine the Bioavailability of TranylcypromineUnited States
-
K-Group Alpha, Inc., a wholly owned subsidiary...Not yet recruiting
-
K-Group, Beta, Inc., a wholly owned subsidiary...Recruiting
-
K-Group, Beta, Inc., a wholly owned subsidiary...Active, not recruitingOsteosarcomaUnited States, France
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
Par Pharmaceutical, Inc.PRA Health SciencesTerminatedAnorexia | Weight Loss | CachexiaUnited States
-
Par Pharmaceutical, Inc.PRA Health SciencesTerminatedAnorexia | Weight Loss | CachexiaUnited States
-
Par Pharmaceutical, Inc.Covance; SFBC AnapharmTerminated
-
Par Pharmaceutical, Inc.Phoenix International Life Sciences, Inc.CompletedTo Determine Bioequivalence Under Fasting ConditionsCanada
-
K-Group, Beta, Inc., a wholly owned subsidiary...PfizerRecruitingMetastatic Colorectal CancerSpain, Australia, United States, Italy, Germany, Poland, Hungary
-
Par Pharmaceutical, Inc.Phoenix International Life Sciences, Inc.CompletedTo Determine Bioequivalence Under Fed ConditionsCanada
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine the Bioequivalence Under Fasting ConditionsUnited States
-
Par Pharmaceutical, Inc.BASi Clinical Research UnitCompletedTo Determine Bioequivalence Under Fasting ConditionsUnited States
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine Bioequivalence Under Fasting Conditions
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine Bioequivalence Under Fasting Conditions